Group 2 Pulmonary Hypertension: Pulmonary Venous Hypertension: Epidemiology and Pathophysiology

被引:15
|
作者
Clark, Craig B. [1 ]
Horn, Evelyn M. [2 ]
机构
[1] Des Moines Univ, Div Cardiol, Dept Internal Med, Iowa Heart Ctr, Des Moines, IA 50312 USA
[2] Weill Cornell Med Ctr, Div Cardiol, Perkin Heart Failure Ctr, 520 East 70th St,Starr Pavilion,4th Floor, New York, NY 10021 USA
关键词
Pulmonary hypertension; Left heart disease; Valvular disease; Epidemiology; Pathophysiology; PRESERVED EJECTION FRACTION; LEFT-HEART DISEASE; RIGHT-VENTRICULAR DYSFUNCTION; FIBROTIC ATRIAL CARDIOMYOPATHY; ARTERY PRESSURE; PHOSPHODIESTERASE-5; INHIBITION; NATRIURETIC PEPTIDE; SYSTOLIC PRESSURE; CARDIAC FIBROSIS; AORTIC-STENOSIS;
D O I
10.1016/j.ccl.2016.04.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary hypertension from left heart disease (PH-LHD) is the most common form of PH, defined as mean pulmonary artery pressure >= 25 mm Hg and pulmonary artery wedge pressure >= 15 mm Hg. PH-LHD development is associated with more severe left-sided disease and its presence portends a poor prognosis, particularly once right ventricular failure develops. Treatment remains focused on the underlying LHD and despite initial enthusiasm for PH-specific therapies, most studies have been disappointing and their routine clinical use cannot be recommended. More work is urgently needed to better understand the pathophysiology underlying this disease and to develop effective therapeutic strategies.
引用
收藏
页码:401 / +
页数:12
相关论文
共 50 条
  • [1] Group 4 Pulmonary Hypertension: Chronic Thromboembolic Pulmonary Hypertension: Epidemiology, Pathophysiology, and Treatment
    Kim, Nick H.
    CARDIOLOGY CLINICS, 2016, 34 (03) : 435 - +
  • [2] Group III Pulmonary Hypertension: Pulmonary Hypertension Associated with Lung Disease: Epidemiology, Pathophysiology, and Treatments
    Klinger, James R.
    CARDIOLOGY CLINICS, 2016, 34 (03) : 413 - +
  • [3] World Health Organization Group I Pulmonary Hypertension Epidemiology and Pathophysiology
    Prins, Kurt W.
    Thenappan, Thenappan
    CARDIOLOGY CLINICS, 2016, 34 (03) : 363 - +
  • [4] Pulmonary Venous and Arterial Remodeling in Experimental Group 2 Pulmonary Hypertension
    Sabbah, Michael S.
    Fayyaz, Ahmed U.
    Griffiths, Leigh G.
    Edwards, William D.
    Dasari, Surendra
    Borlaug, Barry A.
    Redfield, Margaret M.
    CIRCULATION, 2019, 140
  • [5] Pulmonary hypertension caused by pulmonary venous hypertension
    Kulik, Thomas J.
    PULMONARY CIRCULATION, 2014, 4 (04) : 581 - 595
  • [6] Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
    Humbert, M.
    EUROPEAN RESPIRATORY REVIEW, 2010, 19 (115): : 59 - 63
  • [7] Epidemiology of pulmonary hypertension
    Naval, Norma
    INSUFICIENCIA CARDIACA, 2010, 5 (04) : 192 - 196
  • [8] Characterization of Pulmonary Venous Hypertension Patients with Reactive Pulmonary Hypertension as Compared to Proportional Pulmonary Hypertension
    Berger, Gidon
    Hardak, Emilia
    Obaid, Waleed
    Shaham, Beatrice
    Carasso, Shemi
    Kerner, Arthur
    Yigla, Mordechai
    Azzam, Zaher S.
    RESPIRATION, 2012, 83 (06) : 494 - 498
  • [9] PATHOPHYSIOLOGY OF PULMONARY-HYPERTENSION
    TIMMERMANN, H
    SILL, V
    ATEMWEGS-UND LUNGENKRANKHEITEN, 1990, 16 (11) : 530 - 536
  • [10] PATHOPHYSIOLOGY OF PULMONARY-HYPERTENSION
    OLSCHEWSKI, H
    SEEGER, W
    ZEITSCHRIFT FUR KARDIOLOGIE, 1994, 83 : 181 - 191